Major histocompatibility complex class I-related chain A allele mismatching, antibodies, and rejection in renal transplantation

Human Immunology

Volumn 72, Issue 10, 2011, Pages 827-834

  Cox, Steven T ^a   Stephens, Henry A F ^a,b   Fernando, Raymond ^a,b   Karasu, Aliyye ^a,b   Harber, Mark ^b   Howie, Alexander J ^b   Powis, Stephen ^b   Zou, Yizhou ^c   Stastny, Peter ^c   Madrigal, J Alejandro ^a   Little, Ann Margaret ^a  

^a ANTHONY NOLAN RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antibodies; MICA; Mismatching; Rejection; Renal; Transplantation

Indexed keywords

ANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; HLA A ANTIGEN; HLA A ANTIGEN ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 ANTIBODY; MYCOPHENOLIC ACID; POLYSTYRENE; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY REACTION; ARTICLE; DNA SEQUENCE; DONOR; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; ALLELES; ANTIBODY SPECIFICITY; BIOLOGICAL MARKERS; EPITOPES; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HUMANS; ISOANTIBODIES; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TRANSPLANTATION, HOMOLOGOUS;

EID: 80052963496     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.05.004     Document Type: Article

References (45)

1. Meier-Kriesche H.U., Schold J.D., Kaplan B. Long-term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies?. Am J Transplant 2004, 4:1289-1295.
2. Trpkov K., Campbell P., Pazderka F., Cockfield S., Solez K., Halloran P.F., et al. Pathologic features of acute renal allograft rejection associated with donor-specific antibody, Analysis using the Banff grading schema. Transplantation 1996, 61:1586-1592.
3. Lee P.C., Terasaki P.I., Takemoto S.K., Lee P.H., Hung C.J., Chen Y.L., et al. All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies. Transplantation 2002, 74:1192-1194.
4. Worthington J.E., Martin S., Dyer P.A., Johnson R.W. An association between posttransplant antibody production and renal transplant rejection. Transplant Proc 2001, 33:475-476.
5. Brasile L., Rodman E., Shield C.F., Clarke J., Cerilli J. The association of antivascular endothelial cell antibody with hyperacute rejection: A case report. Surgery 1986, 99:637-640.
6. Sumitran-Karuppan S., Tyden G., Reinholt F., Berg U., Moller E. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997, 5:321-327.
7. Bahram S., Bresnahan M., Geraghty D.E., Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci U S A 1994, 91:6259-6263.
8. Stephens H.A., Vaughan R.W., Collins R., Kondeatis E., Theron J., Payne A., et al. Towards a molecular phototyping system for allelic variants of MICA, encoded by polymorphisms in exons 2, 3, and 4 of MHC class I chain-related genes. Tissue Antigens 1999, 53:167-174.
9. Mendoza-Rincon J., Arguello J.R., Perez-Rodriguez M., McWhinnie A., Marsh S.G., Fischer G., et al. Characterization of the MICA polymorphism by sequence-specific oligonucleotide probing. Immunogenetics 1999, 49:471-478.
10. Collins R.W., Stephens H.A., Clare M.A., Vaughan R.W. High resolution molecular phototyping of MICA and MICB alleles using sequence specific primers. Hum Immunol 2002, 63:783-794.
11. Cox S.T., Stephens H.A., Fernando R., Grant J., Madrigal J.A., Little A.M. Two novel MICA alleles, MICA*054 and MICA*056. Tissues Antigens 2009, 73:85-87.
12. Fischer G., Perez-Rodriguez M., Arguello J.R., Cox S.T., McWhinnie A., Travers P.J., et al. Three novel MICB alleles. Tissue Antigens 2000, 55:166-170.
13. Stephens H.A. MICA and MICB genes: Can the enigma of their polymorphism be resolved?. Trends Immunol 2001, 22:378-385.
14. Perez-Rodriguez M., Arguello J.R., Fischer G., Corell A., Cox S.T., Robinson J., et al. Further polymorphism of the MICA gene. Eur J Immunogenet 2002, 29:35-46.
15. Zwirner N.W., Fernandez-Vina M.A., Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 1998, 47:139-148.
16. Molinero L.L., Domaica C.I., Fuertes M.B., Girart M.V., Rossi L.E., Zwirner N.W., et al. Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity. Hum Immunol 2006, 67:170-182.
17. Groh V., Bahram S., Bauer S., Herman A., Beauchamp M., Spies T., et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 1996, 93:12445-12450.
18. Groh V., Steinle A., Bauer S., Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998, 279:1737.
19. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999, 285:727-729.
20. Zwirner N.W., Marcos C.Y., Mirbaha F., Zou Y., Stastny P. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients. Hum Immunol 2000, 61:917-924.
21. Hankey K.G., Drachenberg C.B., Papadimitriou J.C., Klassen D.K., Philosophe B., Bartlett S.T., et al. MIC expression in renal and pancreatic allografts. Transplantation 2002, 73:304-306.
22. Sumitran-Holgersson S., Wilczek H.E., Holgersson J., Soderstrom K. Identification of the nonclassical HLA molecules, MICA, as targets for humoral immunity associated with irreversible rejection of kidney allografts. Transplantation 2002, 74:268-277.
23. Zou Y., Stastny P., Susal C., Dohler B., Opelz G. Antibodies against MICA antigens and kidney-transplant rejection. N Engl J Med 2007, 357:1293-1300.
24. Zou Y., Mirbaha F., Lazaro A., Zhang Y., Lavingia B., Stastny P., et al. MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies. Hum Immunol 2002, 63:30-39.
25. Mizutani K., Terasaki P., Rosen A., Esquenazi V., Miller J., Shih R.N., et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 2005, 5:2265-2272.
26. Zou Y., Heinemann F.M., Grosse-Wilde H., Sireci G., Wang Z., Lavingia B., et al. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Hum Immunol 2006, 67:230-237.
27. Mizutani K., Terasaki P.I., Shih R.N., Pei R., Ozawa M., Lee J., et al. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Hum Immunol 2006, 67:223-229.
28. Terasaki P.I., Ozawa M., Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival. Am J Transplant 2007, 7:408-415.
29. Lemy A., Andrien M., Wissing K.M., Ryhahi K., Vandersarren A., Racape J., et al. Major histocompatibility complex class I chain-related antigen A antibodies: Sensitizing events and impact on renal graft outcomes. Transplantation 2010, 90:168-174.
30. Zou Y., Qin Z., Silveus A., Fan Y., Stastny P. Polymorphisms of MICA recognized by human alloantibodies. Immunogenetics 2009, 61:91-100.
31. Zou Y., Stastny P. Role of MICA in the immune response to transplants. Tissue Antigens 2010, 76:171-176.
32. Zou Y., Han M., Wang Z., Stastny P. MICA allele-level typing by sequence-based typing with computerized assignment of polymorphic sites and short tandem repeats within the transmembrane region. Hum Immunol 2006, 67:145-151.
33. Solez K., Colvin R.B., Racusen L.C., Sis B., Halloran P.F., Birk P.E., et al. Banff 2005 Meeting Report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ("CAN"). Am J Transplant 2007, 7:518-526.
34. Racusen L.C., Colvin R.B., Solez K., Mihatsch M.J., Halloran P.F., Campbell P.M., et al. Antibody-mediated rejection criteria-an addition to the Banff 97 classification of renal allograft rejection. Am J Transplant 2003, 3:708-714.
35. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
36. Duquesnoy R.J., Mostecki J., Hariharan J., Balazs I. Structurally based epitope analysis of major histocompatibility complex class I-related chain A (MICA) antibody specificity patterns. Hum Immunol 2008, 69:826-834.
37. Mizutani K., Terasaki P., Hamdani E., Esquenazi V., Rosen A., Miller J., et al. The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant 2007, 7:1027-1031.
38. Parmar S., de Lima M., Zou Y., Patah P., Liu P., Cano P., et al. Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease. Blood 2009, 114(14):2884-2887.
39. Halloran P.F., Schlaut J., Solez K., Srinivasa N.S. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation 1992, 53:550-555.
40. Worthington J.E., Martin S., Al-Husseini D.M., Dyer P.A., Johnson R.W. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome. Transplantation 2003, 75:1034-1040.
41. Pelletier R.P., Hennessy P.K., Adams P.W., VanBuskirk A.M., Ferguson R.M., Orosz C.G., et al. Clinical significance of MHC-reactive alloantibodies that develop after kidney or kidney-pancreas transplantation. Am J Transplant 2002, 2:134-141.
42. Li L., Wadia P., Chen R., Kambham N., Naesens M., Sigdel T.K., et al. Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc Natl Acad Sci U S A 2009, 106:4148-4153.
43. Li L., Chen A., Chaudhuri A., Kambham N., Sigdel T., Chen R., et al. Compartmental localization and clinical relevance of MICA antibodies after renal transplantation. Transplantation 2010, 89:312-319.
44. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Chapman J.R., Allen R.D., et al. Calcineurin inhibitor nephrotoxicity: Longitudinal assessment by protocol histology. Transplantation 2004, 78:557-565.
45. Suarez-Alvarez B., Alonso-Arias R., Bravo-Mendoza C., Lopez-Vazquez A., Ortega T., Baltar J.M., et al. Identification of epitopes and immunodominant regions on the MICA protein defined by alloantibodies from kidney transplant patients. Transplantation 2009, 88(3 Suppl):568-577.